|
|
|
Volumn 31, Issue 9, 2004, Pages 1407-1410
|
|
A case report of metastatic pancreatic cancer that responded remarkably to the combination of thalidomide, celecoxib and irinotecan
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CELECOXIB;
CYCLOOXYGENASE 2;
DRUG DERIVATIVE;
IRINOTECAN;
ISOENZYME;
MEMBRANE PROTEIN;
MESSENGER RNA;
PROSTAGLANDIN SYNTHASE;
PTGS2 PROTEIN, HUMAN;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
AGED;
ARTICLE;
CASE REPORT;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
METABOLISM;
PANCREAS TUMOR;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CYCLOOXYGENASE 2;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PANCREATIC NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
RNA, MESSENGER;
SULFONAMIDES;
THALIDOMIDE;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 4644271370
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
